4′-C-methyl-2′-deoxyadenosine and 4′-C-ethyl-2′- deoxyadenosine inhibit HIV-1 replication

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2379-2389

  Vu, B Christie ^a   Boyer, Paul L ^a   Siddiqui, Maqbool A ^a   Marquez, Victor E ^a   Hughes, Stephen H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 C METHYL 2 DEOXYADENOSINE AND 4 C ETHYL 2 DEOXYADENOSINE; DEOXYADENOSINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VECTOR; ZIDOVUDINE; 2'-DEOXYADENOSINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DEOXYADENOSINE;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; CELL LINE; CHEMISTRY; DNA REPLICATION; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMERASE CHAIN REACTION;

ANTI-HIV AGENTS; CELL LINE; DEOXYADENOSINES; DNA REPLICATION; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; POLYMERASE CHAIN REACTION;

EID: 79955527089     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01290-10     Document Type: Article

References (45)

1. Arion, D., N. Kaushik, S. McCormick, G. Borkow, and M. A. Parniak. 1998. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′- deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 37:15908-15917.
2. Boyer, P. L., et al. 2007. The nucleoside analogs 4′C-methyl thymidine and 4′C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants. J. Mol. Biol. 371:873-882.
3. Boyer, P. L., J. G. Julias, V. E. Marquez, and S. H. Hughes. 2005. Fixed conformation nucleoside analogs effectively inhibit excision-proficient HIV-1 reverse transcriptases. J. Mol. Biol. 345:441-450.
4. Boyer, P. L., S. G. Sarafianos, E. Arnold, and S. H. Hughes. 2002. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision. J. Virol. 76:9143-9151.
5. Boyer, P. L., S. G. Sarafianos, E. Arnold, and S. H. Hughes. 2001. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J. Virol. 75:4832-4842.
6. Boyer, P. L., et al. 2009. The nucleoside analogue D-Carba T blocks HIV-1 reverse transcription. J. Med. Chem. 52:5356-5364.
7. Chen, C. H., M. Vazquez-Padua, and Y. C. Cheng. 1991. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol. Pharmacol. 39:625-628.
8. Choi, Y., et al. 2003. A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitude. J. Med. Chem. 46:3292-3299.
9. Comin, M. J., et al. 2008. D-(+)-Iso-methanocarbathymidine: a high-affinity substrate for herpes simplex virus 1 thymidine kinase. ChemMedChem 3:1129-1134.
10. Das, K., et al. 2009. Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. J. Biol. Chem. 284:35092-35100.
11. Gao, H. Q., P. L. Boyer, S. G. Sarafianos, E. Arnold, and S. H. Hughes. 2000. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase. J. Mol. Biol. 300:403-418.
12. Hayakawa, H., et al. 2004. Potential of 4′-C-substituted nucleosides for the treatment of HIV-1. Antivir. Chem. Chemother. 15:169-187.
13. Henry, M., et al. 2006. Coexistence of the K65R/L74V and/or K65R/T215Y mutations on the same HIV-1 genome. J. Clin. Virol. 37:227-230.
14. Huang, H., R. Chopra, G. L. Verdine, and S. C. Harrison. 1998. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282:1669-1675.
15. Iversen, A. K., et al. 1996. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J. Virol. 70:1086-1090. (Pubitemid 26029028)
16. Julias, J. G., A. L. Ferris, P. L. Boyer, and S. H. Hughes. 2001. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase. J. Virol. 75:6537-6546.
17. Larder, B. A., and S. D. Kemp. 1989. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246:1155-1158.
18. Marquez, V. E., S. H. Hughes, S. Sei, and R. Agbaria. 2006. The history of N-methanocarbathymidine: the investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent. Antiviral Res. 71:268-275. (Pubitemid 44223765)
19. McMahon, M. A., et al. 2007. The HBV drug entecavir-effects on HIV-1 replication and resistance. N. Engl. J. Med. 356:2614-2621.
20. Meyer, P. R., J. Lennerstrand, S. E. Matsuura, B. A. Larder, and W. A. Scott. 2003. Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation. J. Virol. 77:3871-3877.
21. Meyer, P. R., S. E. Matsuura, A. G. So, and W. A. Scott. 1998. Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 95:13471-13476.
22. Nakata, H., et al. 2007. Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4′-ethynyl-2-fluoro-2′-deoxyadenosine. Antimicrob. Agents Chemother. 51:2701-2708.
23. Obika, S., et al. 2002. Synthesis and conformation of 3′,4′-BNA monomers, 3′-O-4′-C-methyleneribonucleosides. Tetrahedron 58:3039-3049. (Pubitemid 34310348)
24. Oh, J., M. J. McWilliams, J. G. Julias, and S. H. Hughes. 2008. Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo. J. Virol. 82:719-727.
25. Ohrui, H., et al. 2007. 2′-Deoxy-4′-C-ethynyl-2- fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against wide spectrum of HIV-1 strains, favorable toxic profiles, and stability in plasma. Nucleosides Nucleotides Nucleic Acids 26:1543-1546. (Pubitemid 350240765)
26. Ohrui, H., and H. Mitsuya. 2001. 4′-C-substituted-2′- deoxynucleosides: a family of antiretroviral agents which are potent against drug-resistant HIV variants. Curr. Drug Targets Infect. Disord. 1:1-10.
27. Petropoulos, C. J., et al. 2000. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 44:920-928.
28. Rangam, G., N. Z. Rudinger, H. M. Müller, and A. Marx. 2005. Synthesis and application of 4′-C-alkylated uridines as probes for uracil-DNA glycosylase. Synthesis 9:1467-1472. (Pubitemid 40834793)
29. Ray, A. S., et al. 2003. Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis. Biochemistry 42:8831-8841. (Pubitemid 36899827)
30. Sarafianos, S. G., et al. 2002. Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA. EMBO J. 21:6614-6624. (Pubitemid 35448438)
31. Sarafianos, S. G., et al. 1999. Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids. Proc. Natl. Acad. Sci. U. S. A. 96:10027-10032.
32. Sarafianos, S. G., et al. 2001. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20:1449-1461. (Pubitemid 32233984)
33. Sarafianos, S. G., S. H. Hughes, and E. Arnold. 2004. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs. Int. J. Biochem. Cell Biol. 36:1706-1715.
34. Sarafianos, S. G., et al. 2009. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J. Mol. Biol. 385:693-713.
35. Sarafianos, S. G., V. N. Pandey, N. Kaushik, and M. J. Modak. 1995. Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase. Biochemistry 34:7207-7216.
36. Schinazi, R. F., B. A. Larder, and J. W. Mellors. 2000. Mutations in retroviral genes associated with drug resistance: 2000-2001 update. Int. Antiviral News 8:65-91.
37. Schuurman, R., et al. 1995. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J. Infect. Dis. 171:1411-1419.
38. Shirasaka, T., et al. 1995. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. U. S. A. 92:2398-2402.
39. Takebe, Y., and A. Telesnitsky. 2006. Evidence for the acquisition of multidrug resistance in an HIV-1 clinical isolate via human sequence transduction. Virology 351:1-6. (Pubitemid 44037669)
40. Tu, X., et al. 2010. Structural basis of HIV-1 resistance to AZT by excision. Nat. Struct. Mol. Biol. 17:1202-1209.
41. Tuske, S., et al. 2004. Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat. Struct. Mol. Biol. 11:469-474.
42. Waga, T., T. Nishizaki, I. Miyakawa, H. Ohrui, and H. Meguro. 1993. Synthesis of 4′-C-methylnucleosides. Biosci. Biotechnol. Biochem. 57:1433-1438.
43. Waga, T., H. Ohrui, and H. Meguro. 1996. Synthesis and biological evaluation of 4′-C-methyl nucleosides. Nucleosides Nucleotides 15:287-304.
44. Winters, M. A., et al. 1997. Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years. Antimicrob. Agents Chemother. 41:757-762.
45. Youssefyeh, R. D., J. P. H. Verheyden, and J. G. Moffatt. 1979. 4′-Substituted nucleosides. 4. Synthesis of some 4′-hydroxymethyl nucleosides. J. Org. Chem. 44:1301-1309.